Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H18N2O3 |
| Molecular Weight | 274.315 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCNC(=O)C1=CN(COC)C2=C(C=CC=C2)C1=O
InChI
InChIKey=RIPDGZHPNKQLDC-UHFFFAOYSA-N
InChI=1S/C15H18N2O3/c1-3-8-16-15(19)12-9-17(10-20-2)13-7-5-4-6-11(13)14(12)18/h4-7,9H,3,8,10H2,1-2H3,(H,16,19)
| Molecular Formula | C15H18N2O3 |
| Molecular Weight | 274.315 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Terbequinil (previously known as SR 25776), a nootropic agent, is a partial inverse agonist of benzodiazepine receptor with psychostimulant activity. This drug participated in clinical trials for the treatment of cognition disorders and major depressive disorder. However, the development of terbequinil was discontinued during clinical trials in France.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8091361
The effects of SR 25776 (TERBEQUINIL) 500 mg alone and in combination with triazolam 0.25 mg on psychomotor performance and memory were assessed in 8 healthy consenting male volunteers in a double-blind placebo controlled trial
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:10:49 GMT 2025
by
admin
on
Mon Mar 31 18:10:49 GMT 2025
|
| Record UNII |
0DH9WUS03O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C73243
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
65916
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
100000082683
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105466
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
6580
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
SUB10908MIG
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
TERBEQUINIL
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
113079-82-6
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
0DH9WUS03O
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY | |||
|
DTXSID50150281
Created by
admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |